SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KEYS
3. KLAR
4. MRK
5. PANW
6. HD
7. UBER
8. SPY
9. DVLT
10. NBIS

Go back to SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement
(NASDAQ: SABS) Delayed: 3.78 -0.01 (0.26%)
Previous Close $3.79    52 Week High $ 
Open $3.83    52 Week Low $ 
Day High $3.88    P/E N/A 
Day Low $3.76    EPS $ 
Volume 701,272